期刊
NEUROPSYCHOPHARMACOLOGY
卷 29, 期 8, 页码 1451-1461出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.npp.1300444
关键词
Parkinson's disease; adenosine A(2A); MPEP; reaction time task
Recent evidence suggest that antagonism of adenosine A(2A) receptors represent an alternative therapeutic approach to Parkinson's disease (PD). Coactivation of A(2A) and the glutamate subtype 5 metabotropic receptors (mGlu(5)) synergistically stimulates DARPP-32 phosphorylation and c-fos expression in the striatum, This study therefore tested the effects of a joint blockade of these receptor's to alleviate the motor dysfunction in a rat model of PD. 6-Hydroxydopamine infusions in the striatum produced akinetic deficits in rats trained to release a lever after a stimulus in a reaction time (RT) task. At 2 weeks after the lesion, A(2A) and mGlu(5) receptors selective antagonists 8-(3-chlorostyryl)caffeine (CSC) and 2-methyl-6-(phenylethynyl)-pyridine (MPEP) were administered daily for 3 weeks either as a single or joint treatment. Injections of CSC (1.25 mg/kg) and MPEP (1.5 mg/kg) separately or in combination reduced the increase of delayed responses and RTs induced by 6-OHDA lesions, while the same treatment had no effect in controls. Furthermore, coadministration of lower doses of 0.625 mg/kg CSC and 0.375 mg/kg MPEP noneffective as a single treatment promoted a full and immediate recovery of akinesia, which was found to be more efficient than the separate blockade of these receptors. These results demonstrate that the combined inactivation of A(2A) and mGlu(5) receptor potentiate their beneficial effects supporting this pharmacological strategy as a promising anti-Parkinsonian therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据